Up next

Autoplay

The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients

0 Views • 08/18/25
Share
Side Effects
Side Effects
Subscribers
0

Benjamin Ungar from the Icahn School of Medicine at Mount Sinai, New York, USA presents their research findings published in Allergy:

Ungar, B., Hartzell, S., Lozano-Ojalvo, D., et al. (2022), The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients. Allergy. https://doi.org/10.1111/all.15540

Follow Allergy on:
Facebook: https://www.facebook.com/EAACIAllergy
Twitter: https://twitter.com/AllergyEaaci
LinkedIn: https://www.linkedin.com/company/allergy-eaaci
Instagram: https://www.instagram.com/allergy.eaaci

Like, share and comment on our videos, thank you.
https://journalallergy.com/

Show more
0 Comments sort Sort By

Up next

Autoplay